Bowen Hanes & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Sell
38,746
-3,891
-9% -$347K 0.08% 78
2025
Q4
$3.37M Sell
42,637
-100
-0.2% -$7.84K 0.08% 81
2025
Q3
$3.42M Sell
42,737
-3,225
-7% -$275K 0.09% 81
2025
Q2
$4.18M Hold
45,962
0.11% 73
2025
Q1
$4.31M Sell
45,962
-300
-0.6% -$26.9K 0.12% 79
2024
Q4
$4.21M Hold
46,262
0.11% 79
2024
Q3
$4.8M Hold
46,262
0.13% 74
2024
Q2
$4.49M Hold
46,262
0.12% 75
2024
Q1
$4.17M Sell
46,262
-96
-0.2% -$8.13K 0.12% 75
2023
Q4
$3.7M Sell
46,358
-39
-0.1% -$2.93K 0.11% 72
2023
Q3
$3.3M Sell
46,397
-287
-0.6% -$21.5K 0.11% 73
2023
Q2
$3.6M Buy
46,684
+724
+2% +$56K 0.12% 73
2023
Q1
$3.45M Sell
45,960
-225
-0.5% -$16.7K 0.12% 72
2022
Q4
$3.64M Sell
46,185
-6,750
-13% -$506K 0.13% 74
2022
Q3
$3.72M Sell
52,935
-17,729
-25% -$1.39M 0.14% 75
2022
Q2
$5.66M Buy
70,664
+1,530
+2% +$120K 0.21% 73
2022
Q1
$5.24M Sell
69,134
-1,535
-2% -$122K 0.16% 84
2021
Q4
$6.03M Sell
70,669
-3,244
-4% -$253K 0.17% 83
2021
Q3
$5.59M Sell
73,913
-520
-0.7% -$41.3K 0.17% 80
2021
Q2
$6.05M Sell
74,433
-1,240
-2% -$101K 0.18% 76
2021
Q1
$5.96M Sell
75,673
-240
-0.3% -$18.8K 0.19% 79
2020
Q4
$6.49M Sell
75,913
-530
-0.7% -$43.8K 0.22% 73
2020
Q3
$5.9M Sell
76,443
-1,653
-2% -$126K 0.21% 70
2020
Q2
$5.72M Sell
78,096
-5,710
-7% -$406K 0.23% 64
2020
Q1
$5.56M Sell
83,806
-2,160
-3% -$152K 0.27% 62
2019
Q4
$5.92M Sell
85,966
-373,110
-81% -$25.4M 0.24% 62
2019
Q3
$33.7M Buy
459,076
+14,056
+3% +$1.02M 1.43% 33
2019
Q2
$31.9M Sell
445,020
-240
-0.1% -$17K 1.37% 36
2019
Q1
$30.5M Buy
445,260
+72,926
+20% +$4.71M 1.35% 37
2018
Q4
$22.2M Sell
372,334
-7,985
-2% -$500K 1.12% 45
2018
Q3
$25.5M Sell
380,319
-1,191
-0.3% -$79.3K 1.12% 44
2018
Q2
$24.7M Buy
381,510
+143
+0% +$9.35K 1.16% 43
2018
Q1
$27.3M Sell
381,367
-1,010
-0.3% -$72.7K 1.27% 38
2017
Q4
$28.9M Sell
382,377
-4,486
-1% -$328K 1.29% 35
2017
Q3
$28.2M Sell
386,863
-788
-0.2% -$56.8K 1.33% 34
2017
Q2
$28.7M Sell
387,651
-386
-0.1% -$28.7K 1.41% 30
2017
Q1
$28.4M Sell
388,037
-3,090
-0.8% -$216K 1.43% 27
2016
Q4
$25.6M Sell
391,127
-16,125
-4% -$1.11M 1.37% 36
2016
Q3
$30.2M Buy
407,252
+1,063
+0.3% +$78.6K 1.6% 21
2016
Q2
$29.7M Sell
406,189
-1,991
-0.5% -$142K 1.61% 24
2016
Q1
$28.8M Sell
408,180
-22,525
-5% -$1.5M 1.59% 24
2015
Q4
$28.7M Sell
430,705
-87,310
-17% -$5.81M 1.61% 22
2015
Q3
$32.9M Sell
518,015
-10,725
-2% -$701K 1.89% 5
2015
Q2
$34.6M Sell
528,740
-1,605
-0.3% -$109K 1.72% 6
2015
Q1
$36.8M Buy
530,345
+1,555
+0.3% +$107K 1.77% 5
2014
Q4
$36.6M Sell
528,790
-5,960
-1% -$403K 1.79% 3
2014
Q3
$34.9M Sell
534,750
-23,095
-4% -$1.52M 1.7% 7
2014
Q2
$38M Sell
557,845
-13,254
-2% -$888K 1.77% 4
2014
Q1
$37M Sell
571,099
-280
-0% -$17.6K 1.79% 5
2013
Q4
$37.3M Sell
571,379
-36,548
-6% -$2.34M 1.81% 5
2013
Q3
$36M Sell
607,927
-14,475
-2% -$858K 1.84% 4
2013
Q2
$35.7M Buy
+622,402
New +$36.9M 1.91% 7

Other funds holding CL

Bowen Hanes & Co's CL Position: Q1 2026 in Review

Bowen Hanes & Co reduced its Colgate-Palmolive (CL) stake by 9.1% in Q1 2026, selling an estimated $347K and leaving 38,746 shares worth $3.3M. The position accounts for 0.08% of the portfolio, ranked #78.

Bowen Hanes & Co first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $38M in Q2 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Bowen Hanes & Co held 38,746 shares of Colgate-Palmolive worth $3.3M as of Q1 2026.
  • Bowen Hanes & Co sold 3,891 Colgate-Palmolive shares in Q1 2026, an estimated $347K.
  • Colgate-Palmolive made up 0.08% of Bowen Hanes & Co's portfolio in Q1 2026, its #78 holding.
  • Bowen Hanes & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Bowen Hanes & Co's Colgate-Palmolive position peaked at $38M in Q2 2014.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.